Lantus solostar 100 unit/ML 3ML
Ended Awarded
- Contract number
- SPE2DB25FGXQH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,334
Award facts
- Contract value 100% obligated
- $1,333.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL formulations. This firm fixed-price delivery order, valued at $1,333.80, represents a non-set-aside competitive award and is part of AmerisourceBergen's broader relationship with DLA. The contract carries an ultimate completion date of August 22, 2025, with performance to be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a ceiling value of $999.99 million through December 2026.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor supporting federal medical procurement for military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, medical devices, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor registered in the System for Award Management, AmerisourceBergen demonstrates substantial capacity to fulfill federal healthcare requirements through open competition, supporting customers including the Defense Health Agency and U.S. Coast Guard with both brand-name and generic medications essential for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FGXQH?
SPE2DB25FGXQH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FGXQH worth?
The government has obligated $1,334 on SPE2DB25FGXQH.
Is contract SPE2DB25FGXQH an order under another contract?
Yes. SPE2DB25FGXQH is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXQH competed?
The extent of competition for SPE2DB25FGXQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award